{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T17:57:37Z","timestamp":1793555857374,"version":"4.5.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20240127"],"award-info":[{"award-number":["BX20240127"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M761054"],"award-info":[{"award-number":["2024M761054"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.redox.2025.103551","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T16:19:05Z","timestamp":1739549945000},"page":"103551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside"],"prefix":"10.1016","volume":"81","author":[{"given":"Yimin","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfeng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2025.103551_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100896","article-title":"Genetic iron overload disorders","volume":"75","author":"Corradini","year":"2020","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.redox.2025.103551_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molmed.2023.12.002","article-title":"Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia","volume":"30","author":"Pilotto","year":"2024","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.redox.2025.103551_bib3","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s40265-019-01229-3","article-title":"Dimethyl fumarate: a review in relapsing-remitting ms","volume":"79","author":"Blair","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.redox.2025.103551_bib4","series-title":"Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)","year":"2024"},{"key":"10.1016\/j.redox.2025.103551_bib5","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2022-157810","article-title":"Phase 2, randomized, open-label trial of bitopertin in erythropoietic protoporphyria: beacon trial design","volume":"140","author":"Mensing","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.redox.2025.103551_bib6","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.cmet.2024.03.005","article-title":"A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axis","volume":"36","author":"Dong","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103551_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","article-title":"Mechanisms controlling cellular and systemic iron homeostasis","volume":"25","author":"Galy","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.redox.2025.103551_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcmgh.2018.06.006","article-title":"Severe iron metabolism defects in mice with double knockout of the multicopper ferroxidases Hephaestin and ceruloplasmin","volume":"6","author":"Fuqua","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2025.103551_bib9","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.3390\/nu6031080","article-title":"Heme, an essential nutrient from dietary proteins, critically impacts diverse physiological and pathological processes","volume":"6","author":"Hooda","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.redox.2025.103551_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jhep.2015.11.009","article-title":"Iron metabolism and related genetic diseases: a cleared land, keeping mysteries","volume":"64","author":"Brissot","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103551_bib11","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"Nemeth","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.redox.2025.103551_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/iub.1621","article-title":"Ferritin, cellular iron storage and regulation","volume":"69","author":"Arosio","year":"2017","journal-title":"IUBMB Life"},{"key":"10.1016\/j.redox.2025.103551_bib13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0891-5849(02)01006-7","article-title":"The labile iron pool: characterization, measurement, and participation in cellular processes(1)","volume":"33","author":"Kakhlon","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103551_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2018.09.022","article-title":"Iron and redox cycling. Do's and don'ts","volume":"133","author":"Koppenol","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103551_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2024.109579","article-title":"The degradation pathways of contaminants by reactive oxygen species generated in the Fenton\/Fenton-like systems","volume":"35","author":"Zhang","year":"2024","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.redox.2025.103551_bib16","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","article-title":"Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases","volume":"1863","author":"Nakamura","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.redox.2025.103551_bib17","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s12276-022-00829-6","article-title":"The Nrf2 antioxidant defense system in intervertebral disc degeneration: molecular insights","volume":"54","author":"Xiang","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.redox.2025.103551_bib18","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s13238-010-0113-z","article-title":"Human catalase: looking for complete identity","volume":"1","author":"Goyal","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.redox.2025.103551_bib19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2025.103551_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/cts.12868","article-title":"Effects of bardoxolone methyl on hepatic enzymes in patients with type 2 diabetes mellitus and stage 4 CKD","volume":"14","author":"Lewis","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.redox.2025.103551_bib21","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1074\/jbc.M210664200","article-title":"Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones","volume":"278","author":"Pietsch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2025.103551_bib22","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1096\/fj.12-226043","article-title":"Transcriptional regulation of the human ferritin gene by coordinated regulation of Nrf2 and protein arginine methyltransferases PRMT1 and PRMT4","volume":"27","author":"Huang","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.redox.2025.103551_bib23","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3324\/haematol.2009.020123","article-title":"Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE\/ARE sequence motif at position -7007 of the FPN1 promoter","volume":"95","author":"Marro","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.redox.2025.103551_bib24","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1089\/ars.2017.7176","article-title":"The roles of NRF2 in modulating cellular iron homeostasis","volume":"29","author":"Kerins","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2025.103551_bib25","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1182\/blood.2022016987","article-title":"Liver sinusoidal endothelial cells induce BMP6 expression in response to non-transferrin-bound iron","volume":"141","author":"Charlebois","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.redox.2025.103551_bib26","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.freeradbiomed.2015.11.001","article-title":"Phytoestrogens modulate hepcidin expression by Nrf2: implications for dietary control of iron absorption","volume":"89","author":"Bayele","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103551_bib27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s42255-019-0063-6","article-title":"Nrf2 controls iron homeostasis in haemochromatosis and thalassaemia via Bmp6 and hepcidin","volume":"1","author":"Lim","year":"2019","journal-title":"Nat. Metab."},{"key":"10.1016\/j.redox.2025.103551_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117838","article-title":"Nrf2 knockout dysregulates iron metabolism and increases the hemolysis through ROS in aging mice","volume":"255","author":"Liu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.redox.2025.103551_bib29","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-023-02875-x","article-title":"Nrf2 regulates iron-dependent hippocampal synapses and functional connectivity damage in depression","volume":"20","author":"Zeng","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.redox.2025.103551_bib30","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.2022.281995","article-title":"Duality of Nrf2 in iron-overload cardiomyopathy","volume":"108","author":"Federti","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.redox.2025.103551_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109875","article-title":"Upregulation of Nrf2 signaling and suppression of ferroptosis and NF-kappaB pathway by leonurine attenuate iron overload-induced hepatotoxicity","volume":"356","author":"Salama","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.redox.2025.103551_bib32","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1039\/D2FO02716J","article-title":"Kaempferol prevents acetaminophen-induced liver injury by suppressing hepatocyte ferroptosis via Nrf2 pathway activation","volume":"14","author":"Li","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.redox.2025.103551_bib33","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.2147\/DDDT.S409232","article-title":"Galangin attenuates myocardial ischemic reperfusion-induced ferroptosis by targeting nrf2\/Gpx4 signaling pathway","volume":"17","author":"Yang","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.redox.2025.103551_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109257","article-title":"Protective effects of Salvianolic acid B on rat ferroptosis in myocardial infarction through upregulating the Nrf2 signaling pathway","volume":"112","author":"Shen","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.redox.2025.103551_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420921083","article-title":"Long-term outcomes of monascin - a novel dual peroxisome proliferator-activated receptor gamma\/nuclear factor-erythroid 2 related factor-2 agonist in experimental intracerebral hemorrhage","volume":"13","author":"Fu","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"issue":"27","key":"10.1016\/j.redox.2025.103551_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-97-9294-8","article-title":"Fructus Ligustri Lucidi inhibits ferroptosis in ovariectomy-induced osteoporosis in rats via the Nrf2\/HO-1 signaling pathway","volume":"20","author":"Li","year":"2024","journal-title":"Biomed Rep"},{"key":"10.1016\/j.redox.2025.103551_bib37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jhep.2013.09.004","article-title":"Transcription factor NRF2 protects mice against dietary iron-induced liver injury by preventing hepatocytic cell death","volume":"60","author":"Silva-Gomes","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103551_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gut.2007.131722","article-title":"Evidence for differential effects of hepcidin in macrophages and intestinal epithelial cells","volume":"57","author":"Chaston","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.redox.2025.103551_bib39","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3945\/jn.108.102905","article-title":"Hepcidin decreases iron transporter expression in vivo in mouse duodenum and spleen and in vitro in THP-1 macrophages and intestinal Caco-2 cells","volume":"139","author":"Chung","year":"2009","journal-title":"J. Nutr."},{"key":"10.1016\/j.redox.2025.103551_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3324\/haematol.2019.232124","article-title":"Iron metabolism and iron disorders revisited in the hepcidin era","volume":"105","author":"Camaschella","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.redox.2025.103551_bib41","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.cmet.2015.09.006","article-title":"Ironing out ferroportin","volume":"22","author":"Drakesmith","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103551_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113915","article-title":"Biochanin A protects against iron overload associated knee osteoarthritis via regulating iron levels and NRF2\/System xc-\/GPX4 axis","volume":"157","author":"He","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.redox.2025.103551_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154330","article-title":"Naringenin protects against iron overload-induced osteoarthritis by suppressing oxidative stress","volume":"105","author":"Pan","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.redox.2025.103551_bib44","article-title":"Oxidative stress's impact on red blood cells: unveiling implications for health and disease","volume":"103","author":"Obeagu","year":"2024","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.redox.2025.103551_bib45","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jclinpath-2019-205775","article-title":"Abnormal red blood cell morphological changes in thalassaemia associated with iron overload and oxidative stress","volume":"72","author":"Chaichompoo","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.redox.2025.103551_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/biom13081262","article-title":"Oxidative stress in healthy and pathological red blood cells","volume":"13","author":"Orrico","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.redox.2025.103551_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130111","article-title":"Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of beta-thalassemia","volume":"4","author":"Matte","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.redox.2025.103551_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12030740","article-title":"Keap1-Nrf2 heterodimer: a therapeutic target to ameliorate sickle cell disease","volume":"12","author":"Chauhan","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2025.103551_bib49","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1001\/jama.2022.17727","article-title":"Diagnosis and management of hereditary hemochromatosis","volume":"328","author":"Cabrera","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.redox.2025.103551_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tips.2019.02.001","article-title":"Therapeutic prospects for Friedreich's ataxia","volume":"40","author":"Zhang","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2025.103551_bib51","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.redox.2025.103551_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/WCO.0000000000000094","article-title":"Relapsing and progressive forms of multiple sclerosis: insights from pathology","volume":"27","author":"Dutta","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.redox.2025.103551_bib53","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1185\/03007995.2013.849236","article-title":"BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety","volume":"30","author":"Fox","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.redox.2025.103551_bib54","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/ana.21582","article-title":"Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron","volume":"64","author":"Hammond","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2025.103551_bib55","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1148\/radiol.13130474","article-title":"Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease","volume":"270","author":"Walsh","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.redox.2025.103551_bib56","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1352458511428464","article-title":"Quantitative high-field imaging of sub-cortical gray matter in multiple sclerosis","volume":"18","author":"Lebel","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.redox.2025.103551_bib57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1552-6569.2008.00296.x","article-title":"Deep gray matter involvement on brain MRI scans is associated with clinical progression in multiple sclerosis","volume":"19","author":"Neema","year":"2009","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.redox.2025.103551_bib58","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1093\/brain\/awr278","article-title":"Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla","volume":"134","author":"Bagnato","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.redox.2025.103551_bib59","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ana.23974","article-title":"Iron and neurodegeneration in the multiple sclerosis brain","volume":"74","author":"Hametner","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.redox.2025.103551_bib60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneurol.2014.118","article-title":"Iron in multiple sclerosis: roles in neurodegeneration and repair","volume":"10","author":"Stephenson","year":"2014","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.redox.2025.103551_bib61","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2019.10.041","article-title":"Dimethyl fumarate reduces microglia functional response to tissue damage and favors brain iron homeostasis","volume":"439","author":"Pagani","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.redox.2025.103551_bib62","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1084\/jem.20042433","article-title":"TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis","volume":"202","author":"Chen","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.redox.2025.103551_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/antiox9080700","article-title":"Exploring the use of dimethyl fumarate as microglia modulator for neurodegenerative diseases treatment","volume":"9","author":"Rosito","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.redox.2025.103551_bib64","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41582-024-00957-9","article-title":"Approval of omaveloxolone for Friedreich ataxia","volume":"20","author":"Boesch","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.redox.2025.103551_bib65","article-title":"Friedreich ataxia","author":"Williams","year":"2024","journal-title":"In StatPearls"},{"key":"10.1016\/j.redox.2025.103551_bib66","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/mds.25795","article-title":"HFE p.C282Y heterozygosity is associated with earlier disease onset in Friedreich ataxia","volume":"29","author":"Delatycki","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.redox.2025.103551_bib67","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/hmg\/ddi042","article-title":"Friedreich ataxia: the oxidative stress paradox","volume":"14","author":"Seznec","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.redox.2025.103551_bib68","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41419-023-06320-y","article-title":"Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain","volume":"14","author":"Doni","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2025.103551_bib69","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1074\/jbc.274.8.4497","article-title":"The yeast frataxin homologue mediates mitochondrial iron efflux. Evidence for a mitochondrial iron cycle","volume":"274","author":"Radisky","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2025.103551_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104606","article-title":"Friedreich ataxia- pathogenesis and implications for therapies","volume":"132","author":"Delatycki","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2025.103551_bib71","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pjnns.2018.02.003","article-title":"Progress in the treatment of Friedreich ataxia","volume":"52","author":"Tai","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.redox.2025.103551_bib72","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/14737175.2017.1356721","article-title":"Pharmacological therapeutics in Friedreich ataxia: the present state","volume":"17","author":"Strawser","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.redox.2025.103551_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2024.12.041","article-title":"Poincare plot analysis of electrocardiogram uncovers beneficial effects of omaveloxolone in a mouse model of Friedreich ataxia","author":"Figueroa","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.redox.2025.103551_bib74","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tips.2023.03.005","article-title":"Omaveloxolone (Skyclarys(TM)) for patients with Friedreich's ataxia","volume":"44","author":"Dayalan Naidu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.redox.2025.103551_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.952950","article-title":"Omaveloxolone inhibits IL-1beta-induced chondrocyte apoptosis through the Nrf2\/ARE and NF-kappaB signalling pathways in vitro and attenuates osteoarthritis in vivo","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2025.103551_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101309","article-title":"The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-kappab signaling","volume":"28","author":"Sun","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103551_bib77","doi-asserted-by":"crossref","first-page":"C331","DOI":"10.1152\/ajpcell.00467.2023","article-title":"RTA 408 ameliorates diabetic cardiomyopathy by activating Nrf2 to regulate mitochondrial fission and fusion and inhibiting NF-kappaB-mediated inflammation","volume":"326","author":"Hao","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.redox.2025.103551_bib78","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s12035-024-04361-8","article-title":"Omaveloxolone ameliorates cognitive deficits by inhibiting apoptosis and neuroinflammation in APP\/PS1 mice","volume":"62","author":"Liu","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.redox.2025.103551_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106210","article-title":"NRF2 activation suppresses motor neuron ferroptosis induced by the SOD1(G93A) mutation and exerts neuroprotection in amyotrophic lateral sclerosis","volume":"184","author":"Yang","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.redox.2025.103551_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101791","article-title":"The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia","volume":"38","author":"La Rosa","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103551_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103339","article-title":"Deciphering the ferroptosis pathways in dorsal root ganglia of Friedreich ataxia models. The role of LKB1\/AMPK, KEAP1, and GSK3beta in the impairment of the NRF2 response","volume":"76","author":"Sanz-Alcazar","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.redox.2025.103551_bib82","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2025.103551_bib83","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ymgme.2018.08.015","article-title":"Congenital erythropoietic porphyria and erythropoietic protoporphyria: identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations","volume":"128","author":"Weiss","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.redox.2025.103551_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11120798","article-title":"Iron, heme synthesis and erythropoietic porphyrias: a complex interplay","volume":"11","author":"Poli","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.redox.2025.103551_bib85","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood-2014-07-584664","article-title":"Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria","volume":"126","author":"Egan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.redox.2025.103551_bib86","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3324\/haematol.2019.228270","article-title":"Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria","volume":"106","author":"Mirmiran","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.redox.2025.103551_bib87","article-title":"Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy","volume":"27","author":"Blouin","year":"2021","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.redox.2025.103551_bib88","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1182\/blood.2023022193","article-title":"Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders","volume":"144","author":"Pinto","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.redox.2025.103551_bib89","doi-asserted-by":"crossref","first-page":"8192","DOI":"10.1182\/blood-2022-168924","article-title":"Bitopertin, a selective Glycine transporter 1 inhibitor, reduced protoporphyrin IX (PPIX) level and improved liver fibrosis in a mouse model of erythropoietic protoporphyria (EPP)","volume":"140","author":"Wu","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.redox.2025.103551_bib101","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3324\/haematol.2017.170720","article-title":"Ferroportin disease: pathogenesis, diagnosis and treatment","volume":"102","author":"Pietrangelo","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.redox.2025.103551_bib90","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1007\/s00018-020-03747-w","article-title":"Pathogenic mechanism and modeling of neuroferritinopathy","volume":"78","author":"Cozzi","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.redox.2025.103551_bib91","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.stemcr.2019.09.002","article-title":"Stem cell modeling of neuroferritinopathy reveals iron as a determinant of senescence and ferroptosis during neuronal aging","volume":"13","author":"Cozzi","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.redox.2025.103551_bib92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1750-1326-5-50","article-title":"Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy","volume":"5","author":"Barbeito","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.redox.2025.103551_bib93","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-4159.2009.06028.x","article-title":"Abnormal iron metabolism and oxidative stress in mice expressing a mutant form of the ferritin light polypeptide gene","volume":"109","author":"Barbeito","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.redox.2025.103551_bib94","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/mds.29145","article-title":"Conservative iron chelation for neuroferritinopathy","volume":"37","author":"Marchand","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.redox.2025.103551_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.16","article-title":"Haemochromatosis","volume":"4","author":"Brissot","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.redox.2025.103551_bib96","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jhep.2022.03.033","article-title":"EASL clinical practice guidelines on haemochromatosis","volume":"77","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103551_bib97","doi-asserted-by":"crossref","first-page":"e607","DOI":"10.1016\/S2352-3026(17)30214-4","article-title":"Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial","volume":"4","author":"Ong","year":"2017","journal-title":"Lancet Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.redox.2025.103551_bib98","first-page":"s84","article-title":"Erythrocytapheresis compared with whole blood phlebotomy for the treatment of hereditary haemochromatosis","volume":"12","author":"Sundic","year":"2014","journal-title":"Blood Transfus"},{"key":"10.1016\/j.redox.2025.103551_bib99","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(23)00287-8","article-title":"Haemochromatosis","volume":"401","author":"Adams","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2025.103551_bib100","first-page":"42","article-title":"Molecular basis of HFE-hemochromatosis","volume":"5","author":"Vujic","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.redox.2025.103551_bib102","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmet.2014.07.007","article-title":"Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload","volume":"20","author":"Altamura","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.redox.2025.103551_bib103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.freeradbiomed.2018.08.008","article-title":"Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia","volume":"133","author":"Fujiwara","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2025.103551_bib104","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ng.2996","article-title":"Identification of erythroferrone as an erythroid regulator of iron metabolism","volume":"46","author":"Kautz","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.redox.2025.103551_bib105","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/blood.2022019195","article-title":"BMP5 contributes to hepcidin regulation and systemic iron homeostasis in mice","volume":"142","author":"Xiao","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.redox.2025.103551_bib106","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.hoc.2014.04.008","article-title":"Sideroblastic anemia: diagnosis and management","volume":"28","author":"Bottomley","year":"2014","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.redox.2025.103551_bib107","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2174\/138945012802002320","article-title":"Aceruloplasminemia","volume":"13","author":"Kono","year":"2012","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.redox.2025.103551_bib108","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2174\/1570159X16666180508113025","article-title":"Does ceruloplasmin defend against neurodegenerative diseases?","volume":"17","author":"Wang","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.redox.2025.103551_bib109","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jhep.2010.04.039","article-title":"Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation","volume":"53","author":"Finkenstedt","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103551_bib110","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2010.05.016","article-title":"Ferroportin disease: a systematic meta-analysis of clinical and molecular findings","volume":"53","author":"Mayr","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.redox.2025.103551_bib111","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hoc.2022.12.013","article-title":"Clinical challenges with iron chelation in beta thalassemia","volume":"37","author":"Kwiatkowski","year":"2023","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"10.1016\/j.redox.2025.103551_bib112","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/nyas.15052","article-title":"Combination chelation therapy","volume":"1529","author":"Aydinok","year":"2023","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.redox.2025.103551_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085115","article-title":"Combined therapy of iron chelator and antioxidant completely restores brain dysfunction induced by iron toxicity","volume":"9","author":"Sripetchwandee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.redox.2025.103551_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159414","article-title":"Combined iron chelator and antioxidant exerted greater efficacy on cardioprotection than monotherapy in iron-overloaded rats","volume":"11","author":"Wongjaikam","year":"2016","journal-title":"PLoS One"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231725000643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T13:54:27Z","timestamp":1742306067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231725000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":114,"alternative-id":["S2213231725000643"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2025.103551","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 activators for the treatment of rare iron overload diseases: From bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2025.103551","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103551"}}